Study to Compare the Bioavailability of ABT-335 and Rosuvastatin From ABT-143 Relative to That From the Co-administration of ABT-335 and Rosuvastatin Calcium

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

August 31, 2008

Conditions

Adverse EventsPharmacokinetic

Interventions

DRUG

ABT-143

once daily for 6 days

DRUG

ABT-335

once daily for six days

DRUG

Rosuvastatin

Once daily for 6 days

Trial Locations (1)

Site Reference ID/Investigator# 8089, Orlando